Research Archive — Page 29 of 194

Multiple blue-toned sagittal MRI scans of the human brain arranged together, with white technical labels overlaid.
November 11, 2021

The power of white matter

Using a novel analysis of fMRI data, Vanderbilt researchers discovered intriguing patterns of signals in the brain’s white matter, the “conduit” for relaying signals between different brain regions.

Insulin in vials
November 11, 2021

New way to bEET insulin resistance

Signaling molecules called EETs could improve insulin resistance, a primary risk factor for Type 2 diabetes and cardiovascular disease, Vanderbilt researchers have discovered.

Person using a handheld blood glucose meter with a test strip on a fingertip; a lancing device and small container sit nearby.
November 11, 2021

International gathering scrutinizes immune response, beta cell biology in Type 1 diabetes

Two formally dressed men stand beside an award trophy against a black curtain backdrop. The caption identifies them, left to right, as Robert Dittus, MD, MPH, and Stephen Camarata, PhD.
November 11, 2021

Translational Research Forum honors scientific excellence

Vanderbilt University Medical Center’s strength in translational research, which helps “translate” scientific discovery into medical practice, was celebrated recently during the Vanderbilt Translational Research Forum

Roy Zent, MBBCh, PhD, left, Fabian Bock, MD, PhD, and colleagues are studying the factors involved in the maintenance and integrity of the kidney collecting duct.
November 4, 2021

Harrison Society researcher discovers key regulator of kidney cell structure

New research from Vanderbilt could aid efforts to promote kidney regeneration after injury or to develop engineered organs.

Magnifying glass overlaid on blue financial charts, bar graphs, line graphs, statistics, and digital data icons.
November 2, 2021

Shifts in neuroendocrine cancer clinical trial design

Clinical trials that focus on specific types of neuroendocrine neoplasms — heterogeneous tumors that can occur anywhere in the body — will be more likely to enhance drug development for these tumors, Vanderbilt physicians assert.